Status: Not yet recruiting
Treatment Based on High Precision Cardiac Mapping
APOLO-VT aims to evaluate the feasibility, safety, and clinical impact of an integrated multimodal mapping workflow combining non-invasive structural and functional substrate characterization using Volumetric Electrocardiographic Imaging (ECGi) with invasive Electroanatomical Mapping (EAM) to support Ventricular tachycardia (VT) ablation targeting and verification.
Participants needed: 60
Trial details
Phase: Phase 4Age: 18-99Biological sex: AllType: InterventionalSponsor: Hospital Clinic of BarcelonaUpdated: Aug 5, 2026Locations: 1
Eligibility criteria
Age ≥18 years. [+5]
Age <18 years. [+6]